The Polycystic Kidney Disease (PKD) Foundation Names Mount Sinai Health System Partner Clinic
The polycystic kidney disease (PKD) Foundation—the only organization in the U.S. dedicated solely to finding treatments and a cure for PKD recently named Mount Sinai Health System as a PKDF Partner Clinic for their desire to support patients with Autosomal Dominant PKD (ADPKD). The PKDF Foundation has identified fifteen Partner Clinics around the country who will be partnered with clinicians at one of the Foundation’s Centers of Excellence to participate in a mentorship program to collaborate on providing specialized care to individuals with ADPKD.
The PKD Foundation recently announced 28 recipients of their Centers of Excellence program for their dedication in bringing a patient-centered approach to ADPKD care. ADPKD is one of the most common, life-threatening genetic diseases in which fluid-filled cysts develop and enlarge in both kidneys, eventually leading to kidney failure.
Through an extensive process in which applications were reviewed by the COE Advisory Group made up of clinicians and patient stakeholders, Mount Sinai Health System was selected along with 15 other clinics nationwide to receive the recognition as PKDF Partner Clinic.
“Creating a brighter future for the PKD community has always been our goal which we can achieve through strong partnerships with clinics like Mount Sinai Health System who are doing the incredible work of bringing a patient-centered approach to ADPKD care,” said Chris Rusconi, PhD, Interim CEO and Chief Research Officer of the PKD Foundation. “We congratulate Mount Sinai Health System and look forward to working closely with them to help those affected by ADPKD to find better care, maintain and improve their quality of life, and plan for the future. Together we will ensure better patient outcomes as we move closer to our vision of ending PKD.”
“We are very happy to be selected as one of the few designation centers from the PKD foundation. PKD is the most common genetic kidney disease. Both adults and children could suffer from this devastating disease and the treatment is very challenging. Our newly established center could help this group of patients to get most updated treatment and close follow up with expert in this field,” said John Cijiang He, MD, PhD, Irene and Dr. Arthur M. Fishberg Professor of Medicine, Chief of the Division of Nephrology in the Department of Medicine at Mount Sinai Health System.
Since 1982, the PKD Foundation, a 501c(3) non-profit, has proudly funded more than 1,300 research projects and leveraged $1.5B in research funds, making them the largest private funder of PKD research. The organization funds basic, translational, and clinical research, nephrology fellowships, and scientific meetings with a simple goal: to discover and deliver treatments and a cure for PKD.
We’re proud to be a PKD Foundation Partner Clinic! When you have ADPKD, where you go matters. That’s why we aligned with the PKD Foundation to commit to providing excellent ADPKD-specific care. Learn more about what it means to be a PKD Foundation Partner Clinic: (pkdcure.org/carecenters)
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
